Osphos 51 mg/ml

Osphos 51 mg/ml

Osphos, is one of the Dechra Veterinary Products  Brand with its potent active ingredient Clodronic Acid at a concentration of 51 mg/ml, stands at the forefront of veterinary medicine, specifically crafted for the alleviation of clinical forelimb lameness in adult horses. This breakthrough solution targets bone resorptive processes within the distal sesamoid (navicular bone), offering much-needed relief and support for horses experiencing lameness issues.

Key Features:

1. Focused Lameness Alleviation:  It is meticulously designed to address forelimb lameness attributed to bone resorption in the distal sesamoid, commonly associated with conditions such as navicular syndrome.
2. Clodronate for Bone Health: Enriched with clodronate, Osphos Vet actively supports and promotes overall bone health in horses. Its unique formulation is tailored to combat the specific challenges posed by bone resorptive processes.
3. Versatile Application: It is not only effective for lameness linked to the distal sesamoid but also finds application in controlling clinical signs associated with navicular syndrome in horses aged four years and older.
4. FDA-Approved Intramuscular Use: Osphos Vet proudly holds the distinction of being the only bisphosphonate approved by the US Food and Drug Administration (FDA) for intramuscular use in horses. This underscores its credibility and adherence to rigorous regulatory standards.

5. Dual Action Mechanism: Osphos Vet is engineered to prevent bone resorption by reducing the activity of osteoclasts, irrespective of the underlying cause. Furthermore, it plays a pivotal role in averting both bone formation and degeneration, contributing to comprehensive bone health management.
   For More Contact Us:

   Name(required)

   Email(required)

   Website

   Message

   Submit